Halia Therapeutics, Inc.
Clinical trials sponsored by Halia Therapeutics, Inc., explained in plain language.
-
New drug trial offers hope for blood disorder patients
Disease control OngoingThis study is testing an experimental drug called HT-6184 for people with myelodysplastic syndrome (MDS) who have anemia that causes symptoms. The trial aims to see if the drug can improve blood counts and is safe for patients. Participants will receive treatment for 16 to 32 wee…
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Trial for new diabetes duo withdrawn before starting
Disease control TerminatedThis study aimed to see if adding a new drug called ofirnoflast to the existing medication semaglutide (like Ozempic®) was better for blood sugar control and weight loss in adults with type 2 diabetes who were overweight or obese. It was designed as a 12-week trial comparing the …
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC